Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-19-001946
Filing Date
2019-02-14
Accepted
2019-02-14 09:22:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13ga.htm SC 13G/A 121429
2 ex1.htm EX-1 8761
  Complete submission text file 0001493152-19-001946.txt   132107
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Subject) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-48710 | Film No.: 19601477
SIC: 2834 Pharmaceutical Preparations

Mailing Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10011
Business Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10011 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A